Julie_Buring

Julie Buring

Julie Buring

American epidemiologist


Julie Elizabeth Buring is an American epidemiologist and professor at the Harvard T.H. Chan School of Public Health.[1]

Biography

Buring works with Harvard Medical School and Brigham and Women's Hospital. She is a professor in the epidemiology department at Harvard and also a professor at the Boston University School of Public Health.[2][3] She is the chair of the Institutional Review Board of Harvard Medical School.[4][5] She graduated from Pomona College (BA), University of Washington (MS), and the Harvard School of Public Health (ScD).[6]

Research

The focus of Buring's research is the prevention of cardiovascular disease and cancers in women.[4] She connects risk factors such as stroke and blood pressure into her investigation of cardiology. Two of her most well-known clinical trials are a randomized trial of low-dose aspirin and vitamin E in the primary prevention of cardiovascular disease and cancer, along with the use of vitamin D in the prevention of cardiovascular disease and cancer.[7][3]

Awards

Buring received an honorary doctorate from Pomona College.[1] She received the John Snow Award in Epidemiology from the American Public Health Association.[3]


References

  1. "Julie Elizabeth Buring". Harvard T.H. Chan School of Public Health. 2021-01-05. Retrieved 2023-08-12.
  2. "Julie E. Buring, ScD". Boston University School of Public Health. Retrieved 28 April 2023.
  3. "Julie E. Buring". Harvard School of Public Health. Retrieved 28 April 2023.
  4. "Julie Buring, ScD". Boston University. Retrieved 29 April 2023.
  5. Buring, Julie E. (2012-06-12). "Women's Health Study of Low-dose Aspirin and Vitamin E in Apparently Healthy Women". Brigham and Women's Hospital, National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI). {{cite journal}}: Cite journal requires |journal= (help)



Share this article:

This article uses material from the Wikipedia article Julie_Buring, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.